Delivery Order SPE2DB24D2018-SPE2DB25FWSV1

Award Date 2/4/25
Potential Completion Date 2/5/25
Potential Value $6.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order valued at $10,968.25 for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a prescription medication. The contract has an ultimate completion date of January 23, 2025 and is a firm fixed-price award. This contract is part of a larger $999,999,999 Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order valued at $2,296.84 for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a prescription medication. The contract has an ultimate completion date of April 8, 2025 and a pricing type of Firm Fixed Price. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,275.16, is for the delivery of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a prescription medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an Ultimate Completion Date of February 21, 2025. The contract was awarded on February 20, 2025 and does not have a set-aside...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,343.77, is a Firm Fixed Price Delivery Order for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a prescription medication. The contract has an ultimate completion date of January 24, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,815.46, is for the delivery of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a specialty medication. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of January 23, 2025. The contract was awarded on January 22, 2025 and is not designated as a...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,913.83 firm fixed-price delivery order is for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML medication. The contract has an ultimate completion date of January 13, 2025 and was awarded on January 10, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,935.29, is for the delivery of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 27, 2024. The award was made on December 26, 2024, and there was no set-aside...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,296.46, is for the supply of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a diabetes medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 8, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is the...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $18,120.55, is for the delivery of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a prescription medication. This is a firm fixed-price delivery order contract with a completion date of March 26, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,139.33, is a delivery order contract for the supply of OZEMPIC 1 MG/DOSE (4 MG/3 ML) 3ML, a prescription medication. The contract has a period of performance through March 26, 2025 and is a firm fixed-price arrangement. This contract is not set aside for any specific business type....
  • SPE2DB24D2018
    Indefinite Delivery Contract
  • SPE2DB24D2018-SPE2DB25FWSV1
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,409.30, is for the delivery of OZEMPIC 2 MG/DOSE (8 MG/3 ML) 3ML, a prescription medication. The contract is a firm fixed-price delivery order with a completion date of February 5, 2025. The contract was awarded on February 4, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen, as the prime contractor, will be responsible for providing the requested pharmaceutical product to support military and federal healthcare programs. This contract award is part of a larger Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC covers a comprehensive range of pharmaceutical products and medical supplies to meet the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 5/6/25, 11:50 AM